Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14065 | 730 | 35.2 | 76% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TROGLITAZONE | Author keyword | 25 | 21% | 14% | 104 |
2 | JTT 501 | Author keyword | 20 | 100% | 1% | 9 |
3 | CAS 97322 87 7 | Author keyword | 14 | 100% | 1% | 7 |
4 | CS 045 | Author keyword | 13 | 80% | 1% | 8 |
5 | LOBEGLITAZONE | Author keyword | 6 | 80% | 1% | 4 |
6 | ISOXAZOLIDINEDIONE | Author keyword | 4 | 67% | 1% | 4 |
7 | CLIN PHARMACOKINET DYNAM | Address | 3 | 100% | 0% | 3 |
8 | HQL 975 | Author keyword | 3 | 100% | 0% | 3 |
9 | 2 4 THIAZOLIDINEDIONE | Author keyword | 3 | 33% | 1% | 7 |
10 | 3 3 5 DICHLOROPHENYL 2 4 THIAZOLIDINEDIONE | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TROGLITAZONE | 25 | 21% | 14% | 104 | Search TROGLITAZONE | Search TROGLITAZONE |
2 | JTT 501 | 20 | 100% | 1% | 9 | Search JTT+501 | Search JTT+501 |
3 | CAS 97322 87 7 | 14 | 100% | 1% | 7 | Search CAS+97322+87+7 | Search CAS+97322+87+7 |
4 | CS 045 | 13 | 80% | 1% | 8 | Search CS+045 | Search CS+045 |
5 | LOBEGLITAZONE | 6 | 80% | 1% | 4 | Search LOBEGLITAZONE | Search LOBEGLITAZONE |
6 | ISOXAZOLIDINEDIONE | 4 | 67% | 1% | 4 | Search ISOXAZOLIDINEDIONE | Search ISOXAZOLIDINEDIONE |
7 | HQL 975 | 3 | 100% | 0% | 3 | Search HQL+975 | Search HQL+975 |
8 | 2 4 THIAZOLIDINEDIONE | 3 | 33% | 1% | 7 | Search 2+4+THIAZOLIDINEDIONE | Search 2+4+THIAZOLIDINEDIONE |
9 | 3 3 5 DICHLOROPHENYL 2 4 THIAZOLIDINEDIONE | 2 | 67% | 0% | 2 | Search 3+3+5+DICHLOROPHENYL+2+4+THIAZOLIDINEDIONE | Search 3+3+5+DICHLOROPHENYL+2+4+THIAZOLIDINEDIONE |
10 | YM440 | 2 | 67% | 0% | 2 | Search YM440 | Search YM440 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CS 045 | 69 | 61% | 10% | 73 |
2 | ORAL ANTIDIABETIC AGENT | 43 | 58% | 7% | 49 |
3 | CIGLITAZONE | 32 | 55% | 6% | 41 |
4 | ANTIDIABETIC AGENT | 28 | 34% | 9% | 67 |
5 | ANTIDIABETIC AGENT PIOGLITAZONE | 27 | 83% | 2% | 15 |
6 | ANTIDIABETIC AGENT CS 045 | 20 | 52% | 4% | 28 |
7 | ORAL HYPOGLYCEMIC AGENT | 17 | 50% | 3% | 24 |
8 | WISTAR FATTY RATS | 10 | 42% | 3% | 19 |
9 | ANTIDIABETIC AGENT ENGLITAZONE | 10 | 73% | 1% | 8 |
10 | THIAZOLIDINEDIONE | 9 | 17% | 6% | 47 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Thiazolidinediones: a new class of antidiabetic drugs | 1999 | 269 | 108 | 54% |
Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: A review | 2006 | 64 | 62 | 48% |
Clinical pharmacokinetics of troglitazone | 1999 | 85 | 39 | 74% |
Mechanisms of troglitazone hepatotoxicity | 2003 | 98 | 72 | 38% |
Troglitazone - A review of its use in the management of type 2 diabetes mellitus | 1999 | 72 | 90 | 57% |
Thiazolidine-2,4-diones: Progress towards multifarious applications | 2013 | 13 | 127 | 17% |
Troglitazone: Antihyperglycemic activity and potential role in the treatment of type 2 diabetes | 1999 | 50 | 66 | 62% |
Troglitazone and liver injury: In search of answers | 2005 | 57 | 128 | 30% |
The glitazone family of antidiabetic agents | 1996 | 93 | 64 | 80% |
Thiazolidinediones: metabolic actions in vitro | 2002 | 48 | 141 | 36% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN PHARMACOKINET DYNAM | 3 | 100% | 0.4% | 3 |
2 | UMR INSERM U991 | 2 | 67% | 0.3% | 2 |
3 | HIGH QUAL LIFE S | 2 | 40% | 0.5% | 4 |
4 | MED STAT BIOMETAB | 1 | 100% | 0.3% | 2 |
5 | BIOMETAB | 1 | 40% | 0.3% | 2 |
6 | 1785 JUSOHONMACHI 2CHOME | 1 | 50% | 0.1% | 1 |
7 | BIOANAL DRUG METAB PHARMACOKINET | 1 | 50% | 0.1% | 1 |
8 | ERIM 0106 | 1 | 50% | 0.1% | 1 |
9 | MED SIGNALING PATHOL | 1 | 50% | 0.1% | 1 |
10 | NEW FRONTIERS SCI PK N | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000246466 | PIOGLITAZONE//ROSIGLITAZONE//THIAZOLIDINEDIONES |
2 | 0.0000224871 | PPAR DELTA//PPAR BETA DELTA//PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA |
3 | 0.0000126576 | PRO12ALA POLYMORPHISM//PRO12ALA//PPAR GAMMA 2 |
4 | 0.0000112039 | PPAR GAMMA//PPAR RESEARCH//TROGLITAZONE |
5 | 0.0000109864 | SDT FATTY RAT//SDT RAT//PLANNING DEV SECT |
6 | 0.0000098774 | METFORMIN//LACTIC ACIDOSIS//METFORMIN ASSOCIATED LACTIC ACIDOSIS |
7 | 0.0000094883 | METFORMIN HYDROCHLORIDE//PIOGLITAZONE HYDROCHLORIDE//ROSIGLITAZONE MALEATE |
8 | 0.0000091365 | H 411E CELLS//JIANG TANG KE LI JTKL//ADIPOCYTE SECRETED FACTORS |
9 | 0.0000090907 | NATEGLINIDE//KAD 1229//REPAGLINIDE |
10 | 0.0000073888 | REACTIVE METABOLITE//MASS DEFECT FILTER//TIENILIC ACID |